[Congressional Record Volume 171, Number 130 (Tuesday, July 29, 2025)]
[Senate]
[Pages S4837-S4838]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]

  SA 3084. Mrs. MURRAY (for herself and Mr. Justice) submitted an 
amendment intended to be proposed by her to the bill S. 2296, to 
authorize appropriations for fiscal year 2026 for military activities 
of the Department of Defense, for military construction, and for 
defense activities of the Department of Energy, to prescribe military 
personnel strengths for such fiscal year, and for other purposes; which 
was ordered to lie on the table; as follows:

        At the end of subtitle C of title VII, add the following:

     SEC. 724. EVALUATION OF CERTAIN RESEARCH RELATED TO 
                   MENOPAUSE, PERIMENOPAUSE, OR MID-LIFE WOMEN'S 
                   HEALTH.

       (a) In General.--The Secretary of Defense, in coordination 
     with Secretary of Veterans Affairs, shall evaluate--
       (1) the results of completed research related to menopause, 
     perimenopause, or mid-life women's health among women who are 
     members of the uniformed services or veterans;
       (2) the status of such research that is ongoing;
       (3) any gaps in knowledge and research on--
       (A) treatments for menopause-related symptoms, including 
     hormone and non-hormone treatments;
       (B) the safety and effectiveness of treatments for 
     menopause-related symptoms;
       (C) the relation of service in the uniformed services to 
     perimenopause and menopause and the impact of such service on 
     perimenopause and menopause; and
       (D) the impact of perimenopause and menopause on the mental 
     health of women who are members of the uniformed services or 
     veterans;

[[Page S4838]]

       (4) the availability of and uptake of professional training 
     resources for covered providers relating to mid-life women's 
     health with respect to the care, treatment, and management of 
     perimenopause and menopausal symptoms, and related support 
     services; and
       (5) the availability of and uptake of treatments for women 
     who are members of the uniformed services or veterans who are 
     experiencing perimenopause or menopause.
       (b) Report; Strategic Plan.--Not later than 180 days after 
     the date of the enactment of this Act, the Secretary of 
     Defense and the Secretary of Veterans Affairs shall each 
     submit to Congress a report containing--
       (1) the findings of the evaluation conducted under 
     subsection (a);
       (2) recommendations for improving professional training 
     resources described in subsection (a)(4) for covered 
     providers; and
       (3) a strategic plan that--
       (A) resolves the gaps in knowledge and research identified 
     in the report; and
       (B) identifies topics in need of further research relating 
     to potential treatments for menopause-related symptoms of 
     women who are members of the uniformed services or veterans.
       (c) Nonduplication and Supplementation of Efforts.--In 
     carrying out activities under this section, the Secretary of 
     Defense and the Secretary of Veterans Affairs shall ensure 
     that such activities minimize duplication and supplement, not 
     supplant, existing information-sharing efforts of the 
     Department of Health and Human Services.
       (d) Sense of Congress on Additional Research Related to 
     Menopause, Perimenopause, or Mid-life Women's Health.--It is 
     the sense of Congress that the Secretary of Defense and the 
     Secretary of Veterans Affairs should each conduct research 
     related to menopause, perimenopause, or mid-life health 
     regarding women who are members of the uniformed services or 
     veterans.
       (e) Definitions.--In this section:
       (1) Covered provider.--The term ``covered provider'' means 
     a health care provider employed by the Department of Defense 
     or the Department of Veterans Affairs.
       (2) Menopause.--The term``menopause'' means the stage of a 
     woman's life--
       (A) when menstrual periods stop permanently and she can no 
     longer get pregnant; and
       (B) that is not a disease state, but a normal part of aging 
     for women.
       (3) Mid-life.--The term``mid-life'' means a life stage 
     that--
       (A) coincides with the menopausal transition in women, 
     which may be physical or emotional;
       (B) encompasses the late reproductive age, which can begin 
     at approximately 35 years of age, to the late postmenopausal 
     stages of reproductive aging, which can extend to 
     approximately 65 years of age; and
       (C) often marks the onset of many chronic diseases.
       (4) Perimenopause.--The term ``perimenopause'' means the 
     time during a woman's life when levels of the hormone 
     estrogen fall unevenly in a woman's body and is also called 
     the menopausal transition.
       (5) Postmenopausal.--The term ``postmenopausal'' means the 
     stage of a woman's life after a woman has been without a 
     menstrual period for 12 months that lasts for the rest of a 
     woman's life and reflects a time when women are at increased 
     risk for osteoporosis and heart disease.
                                 ______